{
    "2020-07-22": [
        [
            {
                "time": "2023-10-01",
                "original_text": "牛股频频出没！高瓴押注CRO背后的考量",
                "features": {
                    "keywords": [
                        "牛股",
                        "高瓴",
                        "CRO",
                        "押注"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药科创板生物医药投资定期报告：科创板生物医药投资手册第30期",
                "features": {
                    "keywords": [
                        "医药",
                        "科创板",
                        "生物医药",
                        "投资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "科创板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "第三家!“A+H”两地上市的CRO企业哪家强？",
                "features": {
                    "keywords": [
                        "A+H",
                        "两地上市",
                        "CRO",
                        "企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "CRO",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}